Quality of counseling for self-administering injectable contraception: field evidence from mystery client interactions in Lagos, Nigeria
Preprint
- 24 March 2025
- preprint
- Published by F1000 Research Ltd in VeriXiv
Abstract
No abstract availableAll Related Versions
- Version 1, 2025-03-24, VeriXiv
- Published version: BMC Women's Health, 25 (S1), 1.
Funding Information
- Bill and Melinda Gates Foundation (OPP1216593)
This publication has 16 references indexed in Scilit:
- Reasons for discontinuation of contraception among women with a current unintended pregnancy in 36 low and middle-income countriesContraception, 2020
- Self care interventions to advance health and wellbeing: a conceptual framework to inform normative guidanceBMJ, 2019
- Introducing the subcutaneous depot medroxyprogesterone acetate injectable contraceptive via social marketing: lessons learned from Nigeria's private sectorContraception, 2018
- Predictors of DMPA-SC continuation among urban Nigerian women: the influence of counseling quality and side effectsContraception, 2018
- Client and provider experiences with self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in MalawiContraception, 2018
- Designing a global monitoring system for pilot introduction of a new contraceptive technology, subcutaneous DMPA (DMPA-SC)Evaluation and Program Planning, 2018
- Contraceptive service provider imposed restrictions to contraceptive access in Urban NigeriaBMC Health Services Research, 2017
- Underuse of modern methods of contraception: underlying causes and consequent undesired pregnancies in 35 low- and middle-income countriesHuman Reproduction, 2015
- Observational study of the acceptability of Sayana® Press among intramuscular DMPA users in Uganda and SenegalContraception, 2014
- Outcomes for Implementation Research: Conceptual Distinctions, Measurement Challenges, and Research AgendaAdministration and Policy in Mental Health and Mental Health Services Research, 2010